Using recombinant human thyroid‐stimulating hormone for the diagnosis of recurrent thyroid cancer

No abstract is available for this paper.

• Publication year

  2005

• Venue

  ANZ journal of surgery

• Publication date

  2005-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1445-2197.2005.03281.xPMID 15740509
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The use of recombinant human TSH in the follow‐up of differentiated thyroid cancer: experience from a large patient cohort in a single centre

  2002cited by this paper
• Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?

  2002cited by this paper
• Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma.

  2001cited by this paper
• Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administration.

  2001cited by this paper
• Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma.

  2001cited by this paper
• A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.

  1999cited by this paper
• [Evidence-based health care].

  1999cited by this paper
• Hemiplegia after thyrotropin alfa in a hypothyroid patient with thyroid carcinoma metastatic to the brain.

  1999cited by this paper
• Deriving a preference-based single index from the UK SF-36 Health Survey.

  1998cited by this paper
• How to Calculate Indirect Costs in Economic Evaluations

  1998cited by this paper
• Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.

  1997cited by this paper
• Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study).

  1994cited by this paper

• A systematic review of health state utility values for thyroid cancer

  2020cites this paper
• Value within otolaryngology: Assessment of the cost-utility analysis literature

  2016cites this paper
• Composition comprising recombinant human thyroid stimulating hormone and method for producing recombinant human thyroid stimulating hormone

  2016cites this paper
• Composition comprenant une thyréostimuline humaine recombinée et procédé de production de ladite hormone

  2016cites this paper
• Recombinant human TSH versus hypo thyroidism

  2010cites this paper
• Recombinant human TSH versus hypothyroidism. Cost-minimization-analysis in the follow-up care of differentiated thyroid carcinoma.

  2010cites this paper
• Seguimiento de pacientes con cáncer de tiroides que recibieron ablación con radioyodo previa administración de TSHrh

  2010cites this paper
• Surgery and radioablation therapy combined: introducing a 1-week-condensed procedure bonding total thyroidectomy and radioablation therapy with recombinant human TSH.

  2009cites this paper
• Reproducibility of bladder pressure measurements in critically ill patients

  2007cites this paper
• How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer

  2007cites this paper
• Cost-effectiveness of using recombinant human TSH prior to radioiodine ablation for thyroid cancer, compared with treating patients in a hypothyroid state: the German perspective.

  2006cites this paper